BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29534956)

  • 1. Effectiveness of Implemented Interventions on Pathologic Nodal Staging of Non-Small Cell Lung Cancer.
    Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Levy P; Wiggins L; Sachdev V; Robbins T; Spencer D; Osarogiagbon RU
    Ann Thorac Surg; 2018 Jul; 106(1):228-234. PubMed ID: 29534956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.
    Osarogiagbon RU; Ray MA; Fehnel C; Akinbobola O; Saulsberry A; Dortch K; Faris NR; Matthews AT; Smeltzer MP; Spencer D;
    Ann Thorac Surg; 2024 Mar; 117(3):576-584. PubMed ID: 37678613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes After Use of a Lymph Node Collection Kit for Lung Cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study.
    Osarogiagbon RU; Smeltzer MP; Faris NR; Ray MA; Fehnel C; Ojeabulu P; Akinbobola O; Meadows-Taylor M; McHugh LM; Halal AM; Levy P; Sachdev V; Talton D; Wiggins L; Shu XO; Shyr Y; Robbins ET; Klesges LM
    J Thorac Oncol; 2021 Apr; 16(4):630-642. PubMed ID: 33607311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of a Lymph Node Collection Kit Versus Heightened Awareness on Lung Cancer Surgery Quality and Outcomes.
    Ray MA; Fehnel C; Akinbobola O; Faris NR; Taylor M; Pacheco A; Smeltzer MP; Osarogiagbon RU
    J Thorac Oncol; 2021 May; 16(5):774-783. PubMed ID: 33588112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
    Cerfolio RJ; Bryant AS; Minnich DJ
    Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upstaging and survival after robotic-assisted thoracoscopic lobectomy for non-small cell lung cancer.
    Toosi K; Velez-Cubian FO; Glover J; Ng EP; Moodie CC; Garrett JR; Fontaine JP; Toloza EM
    Surgery; 2016 Nov; 160(5):1211-1218. PubMed ID: 27665362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality Criteria.
    Osarogiagbon RU; Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Signore RS; McHugh LM; Levy P; Wiggins L; Sachdev V; Robbins ET
    Ann Thorac Surg; 2017 May; 103(5):1557-1565. PubMed ID: 28366464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival Implications of Variation in the Thoroughness of Pathologic Lymph Node Examination in American College of Surgeons Oncology Group Z0030 (Alliance).
    Osarogiagbon RU; Decker PA; Ballman K; Wigle D; Allen MS; Darling GE
    Ann Thorac Surg; 2016 Aug; 102(2):363-9. PubMed ID: 27262908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of unexpected and expected pathologic N1 non-small cell lung cancer.
    Shin S; Kim HK; Choi YS; Kim K; Kim J; Shim YM
    Ann Thorac Surg; 2013 Sep; 96(3):969-75; discussion 975-6. PubMed ID: 23916803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy.
    Lee PC; Kamel M; Nasar A; Ghaly G; Port JL; Paul S; Stiles BM; Andrews WG; Altorki NK
    Ann Thorac Surg; 2016 Mar; 101(3):1116-22. PubMed ID: 26654728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive mediastinal staging for resected non-small cell lung cancer in a population-based cohort.
    Osarogiagbon RU; Lee YS; Faris NR; Ray MA; Ojeabulu PO; Smeltzer MP
    J Thorac Cardiovasc Surg; 2019 Oct; 158(4):1220-1229.e2. PubMed ID: 31147169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonexamination of lymph nodes and survival after resection of non-small cell lung cancer.
    Osarogiagbon RU; Yu X
    Ann Thorac Surg; 2013 Oct; 96(4):1178-1189. PubMed ID: 23910633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort.
    Faris NR; Smeltzer MP; Lu F; Fehnel CL; Chakraborty N; Houston-Harris CL; Robbins ET; Signore RS; McHugh LM; Wolf BA; Wiggins L; Levy P; Sachdev V; Osarogiagbon RU
    Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):91-101. PubMed ID: 28684006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual intervention to improve pathologic staging of resectable lung cancer.
    Osarogiagbon RU; Ramirez RA; Wang CG; Miller LE; Smeltzer MM; Sareen S; Javed AY; Robbins SG; Khandekar A; Wolf BA; Gibson J; Spencer D; Robbins ET
    Ann Thorac Surg; 2013 Dec; 96(6):1975-81. PubMed ID: 24067333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.